Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a
- 1 August 1994
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 107 (2) , 479-485
- https://doi.org/10.1016/0016-5085(94)90174-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Long-Term Mortality after Transfusion-Associated Non-A, Non-B HepatitisNew England Journal of Medicine, 1992
- Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trialJournal of Hepatology, 1990
- Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experienceJournal of Hepatology, 1990
- A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control groupJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot studyJournal of Medical Virology, 1985